Related Experiment Video

Updated: Jul 15, 2026

Sequential In vivo Imaging of Osteogenic Stem/Progenitor Cells During Fracture Repair
10:30

Sequential In vivo Imaging of Osteogenic Stem/Progenitor Cells During Fracture Repair

Published on: May 23, 2014

Isovitexin can Alleviate Fracture-Related Infection, Promote Osteogenesis, and Inhibit Activation of the NF-κB

Yaping Gu1, Ping Xu2

  • 1Disinfection Supply Center, Suzhou Hospital of Integrated Traditional Chinese and Western Medicine, Suzhou, Jiangsu 215101, China.

Archivum Immunologiae Et Therapiae Experimentalis
|July 13, 2026
PubMed

Insights

Isovitexin, a natural flavonoid, effectively combats fracture-related infections by reducing inflammation and promoting bone healing. It inhibits the NF-κB pathway, offering a potential new therapeutic option for orthopedic infections.

Area of Science:

  • Orthopedics
  • Pharmacology
  • Immunology

Background:

  • Fracture-related infections impede bone healing and cause prolonged inflammation.
  • The therapeutic potential of isovitexin, a natural flavonoid, in fracture infection remains unexplored.
  • Current treatments face challenges in managing infection and promoting bone regeneration.

Purpose of the Study:

  • To investigate the efficacy of isovitexin in a rat model of fracture-related infection.
  • To evaluate isovitexin's effects on bone healing, inflammation, and related molecular pathways.
  • To determine if isovitexin can serve as a viable therapeutic agent for fracture infections.

Main Methods:

  • Established a rat fracture infection model, divided into control, model, Vancomycin, and isovitexin groups.
  • Assessed bone healing via tissue staining and measured inflammatory factors and bone metabolism using ELISA and biochemical kits.
  • Examined osteogenesis and NF-κB pathway protein expression via Western blot.

Main Results:

  • Isovitexin significantly reduced inflammatory cell infiltration and enhanced callus formation compared to Vancomycin.
  • Isovitexin treatment improved bone metabolism, upregulated osteogenic proteins (BMP2, OPN, RUNX2), and modulated inflammatory cytokines (decreased TNF-α, IL-6; increased IL-10).
  • Isovitexin markedly inhibited the activation of the Nuclear Factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling pathway.

Conclusions:

  • Isovitexin demonstrates potent anti-inflammatory and bone-healing properties in fracture-related infections.
  • Isovitexin promotes osteogenesis and suppresses the NF-κB signaling pathway, mitigating infection-induced inflammation.
  • Isovitexin presents a promising therapeutic candidate for managing fracture-related infections and enhancing bone repair.
Keywords:
Fracture-related infectionInflammationIsovitexinMRSANF-κB signaling pathwayOsteogenesis

More Related Videos

Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice06:10

Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice

Published on: September 16, 2020

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Fractures: Bone Repair01:27

Fractures: Bone Repair

Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...